Table 3.
Therapeutic Efficacy of Response and ETS.
| Variable | Total (N = 63) No. (%) | NLR low (N = 30) No. (%) | NLR high (N = 33) No. (%) | P value |
|---|---|---|---|---|
| Complete response (CR) | 11 (17.5) | 10 (33.3) | 1 (3.0) | 0.002 |
| Partial response (PR) | 28 (44.4) | 16 (53.4) | 12 (36.4) | |
| Stable disease (SD) | 16 (25.4) | 4 (13.3) | 12 (36.4) | |
| Progressive disease (PD) | 8 (12.7) | 0 (0) | 8 (24.2) | |
| Objective response rate (ORR) | 39(61.9) | 26 (86.7) | 13 (39.4) | <0.001 |
| Disease control rate (DCR) | 55(87.3) | 30 (100) | 25 (75.8) | 0.012 |
| Early tumor shrinkage (ETS) ≥ 10% | 29 (46) | 22 (73.3) | 7 (21.1) | <0.001 |
Abbreviations: NLR, neutrophil-to-lymphocyte ratio.